REVISED PREDICTIVE BIOMARKER FOR OCRIPLASMIN THERAPY IN VITREOMACULAR TRACTION DISORDERS : RETINA

Secondary Logo

Journal Logo

Original Study

REVISED PREDICTIVE BIOMARKER FOR OCRIPLASMIN THERAPY IN VITREOMACULAR TRACTION DISORDERS

Al-Nawaiseh, Sami MD*; Rickmann, Annekatrin MD*,†; Seuthe, Anna-Maria MD*; Al-Rimawi, Dalia MSc; Viktor Stanzel, Boris PD, Dr. Med*,†; Szurman, Peter PD, Dr. Med*,†

Author Information
Retina 41(12):p 2549-2555, December 2021. | DOI: 10.1097/IAE.0000000000003244

You can read the full text of this article if you:

Access through Ovid